A telehealth-based randomized controlled trial: A model for outpatient trials of off-label medications during the COVID-19 pandemic

Clin Trials. 2021 Aug;18(4):514-517. doi: 10.1177/17407745211011577. Epub 2021 May 20.

Abstract

The study was registered at clinicaltrials.gov: NCT04363203

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Ambulatory Care / methods*
  • Anti-Bacterial Agents / therapeutic use
  • Arrhythmias, Cardiac
  • Azithromycin / therapeutic use
  • COVID-19 Drug Treatment*
  • Enzyme Inhibitors / therapeutic use
  • Humans
  • Hydroxychloroquine / therapeutic use
  • Patient Selection*
  • Randomized Controlled Trials as Topic / methods*
  • Risk Assessment
  • SARS-CoV-2
  • Telemedicine / methods*
  • United States
  • United States Department of Veterans Affairs
  • Veterans

Substances

  • Anti-Bacterial Agents
  • Enzyme Inhibitors
  • Hydroxychloroquine
  • Azithromycin

Associated data

  • ClinicalTrials.gov/NCT04363203